Lifeward (NASDAQ:LFWD) Announces Quarterly Earnings Results, Misses Estimates By $3.53 EPS

Lifeward (NASDAQ:LFWD) released its earnings results on Thursday, March 19th. The company reported ($3.60) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($3.53), Zacks reports. Lifeward had a negative return on equity of 145.55% and a negative net margin of 90.38%.The firm had revenue of $5.08 million for the quarter, compared to analyst estimates of $7.87 million.

Lifeward Trading Up 0.7%

LFWD stock traded up $0.04 during mid-day trading on Friday, reaching $6.34. 5,391 shares of the stock traded hands, compared to its average volume of 26,765. Lifeward has a 52-week low of $4.14 and a 52-week high of $22.56. The company has a market cap of $9.71 million, a P/E ratio of -0.34 and a beta of 0.12. The stock’s fifty day moving average is $6.77 and its 200-day moving average is $7.39.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Citadel Advisors LLC boosted its holdings in shares of Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares during the period. HRT Financial LP increased its stake in Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after buying an additional 29,423 shares during the period. Jane Street Group LLC lifted its position in Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares in the last quarter. Finally, Virtu Financial LLC lifted its position in Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after buying an additional 37,037 shares in the last quarter. 26.76% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on LFWD shares. HC Wainwright upped their target price on Lifeward to $10.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $10.00.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.